Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus
- PMID: 25972364
- DOI: 10.1177/0961203315585813
Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus
Abstract
Introduction: Many studies have shown that differences were observed between male and female lupus patients. Although systemic lupus erythematosus (SLE) affects mostly females (female:male ratio 9:1), male SLE patients show higher mortality due to kidney and neurological disease. Currently there are limited epidemiological data concerning lupus in the Chinese population. As such, the Chinese SLE Treatment and Research group (CSTAR) developed the first online registry of Chinese lupus patients in 2009, and represents a multicenter observational study that attempts to describe and compile the major clinical characteristics of lupus in Chinese patients.
Objective: To investigate the effect of gender on the phenotypes of Chinese SLE patients.
Patients and methods: Data for 2104 SLE patients were prospectively collected and included in the CSTAR registry. Patients fulfilled the 1997 American College of Rheumatology (ACR) SLE classification criteria. We conducted a cross-sectional case-control study to analyze patient clinical and laboratory data at onset and at enrollment. SLE disease activity scores (SLEDAI) were also measured at enrollment.
Results: This study included 1914 women and 190 men. Males and females showed no differences in mean ages at onset, delay of diagnosis and disease duration. Males presented more frequently with fever (p = 0.003), while musculoskeletal involvement (p = 0.001) and cytopenia (p = 0.017) was more common in females as the initial manifestation at onset of SLE. For manifestations at enrollment, males presented more frequently with fever (p = 0.005), renal disease (p = 0.019), vasculitis (p = 0.032) and neuropsychiatric lupus (p = 0.007). For cumulative manifestations at enrollment, males presented more frequently with discoid rash (p < 0.001) and neuropsychiatric lupus (p = 0.036), while less frequently with arthritis (p = 0.011). However, the laboratory data showed no significant differences between the two groups at enrollment. Males also had higher SLEDAI scores at enrollment (p = 0.002).
Conclusions: Renal disease, vasculitis and neuropsychiatric lupus are more common in male SLE patients with higher SLEDAI scores compared to female SLE patients in China.
Keywords: SLEDAI; Systemic lupus erythematosus (SLE); gender.
© The Author(s) 2015.
Similar articles
-
Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes.Lupus. 2019 Apr;28(5):635-641. doi: 10.1177/0961203319839845. Epub 2019 Apr 2. Lupus. 2019. PMID: 30939980
-
Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus.Lupus. 2013 Oct;22(11):1192-9. doi: 10.1177/0961203313499086. Epub 2013 Aug 20. Lupus. 2013. PMID: 23963101
-
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII.Chin Med J (Engl). 2022 Sep 20;135(18):2191-2199. doi: 10.1097/CM9.0000000000002360. Chin Med J (Engl). 2022. PMID: 36525605 Free PMC article.
-
Neuropsychiatric involvement in systemic lupus erythematosus.Curr Rheumatol Rep. 2002 Aug;4(4):337-44. doi: 10.1007/s11926-002-0043-8. Curr Rheumatol Rep. 2002. PMID: 12126586 Review.
-
[Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus].Rev Med Interne. 2012 Sep;33(9):491-502. doi: 10.1016/j.revmed.2012.03.356. Epub 2012 May 11. Rev Med Interne. 2012. PMID: 22579860 Review. French.
Cited by
-
The Systemic Lupus Erythematosus Interventional Trials in Mainland China: A Continuous Challenge.Front Immunol. 2022 Apr 11;13:848478. doi: 10.3389/fimmu.2022.848478. eCollection 2022. Front Immunol. 2022. PMID: 35479089 Free PMC article.
-
Lupus Cohorts.Rheum Dis Clin North Am. 2021 Aug;47(3):457-479. doi: 10.1016/j.rdc.2021.04.009. Epub 2021 Jun 10. Rheum Dis Clin North Am. 2021. PMID: 34215374 Free PMC article. Review.
-
2020 Chinese Guidelines for the Diagnosis and Treatment of Systemic Lupus Erythematosus.Rheumatol Immunol Res. 2020 Dec 1;1(1):5-23. doi: 10.2478/rir-2020-0009. eCollection 2020 Dec. Rheumatol Immunol Res. 2020. PMID: 36465077 Free PMC article.
-
Urinary Albumin Levels are Independently Associated with Renal Lesion Severity in Patients with Lupus Nephritis and Little or No Proteinuria.Med Sci Monit. 2017 Feb 3;23:631-639. doi: 10.12659/msm.899973. Med Sci Monit. 2017. PMID: 28157833 Free PMC article.
-
The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020.Rheumatol Immunol Res. 2022 Apr 20;3(1):38-44. doi: 10.2478/rir-2022-0006. eCollection 2022 Mar. Rheumatol Immunol Res. 2022. PMID: 36467018 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials